TITLE

Avecia in skin tissue project

AUTHOR(S)
O'Driscoll, Catherine
PUB. DATE
May 2006
SOURCE
ICIS Chemical Business;5/1/2006, Vol. 1 Issue 17, p38
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article reports on the plans of Avecia Biotechnology to take part in a project aimed at manufacturing stem cells used to make new skin tissue for burns victims in 2006. Jointly funded by Avecia and the British Department of Trade and Industry, project partners include the Centre for Stem Cell Discovery & Regenerative Medicine of the Durham University and the Blond McIndoe Centre.
ACCESSION #
20864691

 

Related Articles

  • Identification of p63+ keratinocyte progenitor cells in circulation and their matrix-directed differentiation to epithelial cells. Nair, Renjith P.; Krishnan, Lissy K. // Stem Cell Research & Therapy;2013, Vol. 4 Issue 2, p1 

    Introduction: In the event of chronic diabetes or burn wounds, accomplishing skin regeneration is a major concern. Autologous skin grafting is the most effective remedy, but the tissue harvest may create more nonhealing wounds. Currently available skin substitutes have a limited clinical outcome...

  • Gene and stem cell therapy combination could aid wound healing, Hopkins researchers find.  // Transplant News;Oct2013, Vol. 23 Issue 10, p6 

    The article focuses on the study conducted by researchers at John's Hopkins University School of Medicine which examines the use of combined gene and stem cell therapy in wound healing. It says that the researchers have observed the healing process in mice with burn wounds through the increase...

  • Stem Cell Therapy: A New Treatment for Burns? Arno, Anna; Smith, Alexandra H.; Blit, Patrick H.; Shehab, Mohammed Al; Gauglitz, Gerd G.; Jeschke, Marc G. // Pharmaceuticals;Oct2011, Vol. 4 Issue 10, p1355 

    Stem cell therapy has emerged as a promising new approach in almost every medicine specialty. This vast, heterogeneous family of cells are now both naturally (embryonic and adult stem cells) or artificially obtained (induced pluripotent stem cells or iPSCs) and their fates have become...

  • Why are there regional differences in stem cell transplantation activity? An EBMT analysis. Gratwohl, A.; Baldomero, H.; Frauendorfer, K.; Niederweiser, D. // Bone Marrow Transplantation;Aug2008 Supplement, Vol. 42, pS7 

    Differences in the number of hematopoietic SCTs (HSCT), in transplant rates, in indications and in techniques between countries have been reported. They were attributed mainly to differences in the economic situation of the countries or to differences in prevalences of the disease. On the basis...

  • Hematopoietic cell transplantation activity in Europe for inherited metabolic diseases: open issues and future directions. Rovelli, AM; Steward, CG // Bone Marrow Transplantation;Mar2005 Supplement 1, Vol. 35, p23 

    Summary:For the past two decades, hematopoietic cell transplantation (HCT) has been used as effective therapy for selected inherited metabolic diseases (IMD). The primary goals of this therapy have been to promote long-term survival with donor-derived engraftment and to optimize quality of life....

  • Stem cell transplants favourable for acute leukaemia.  // PharmacoEconomics & Outcomes News;9/8/2007, Issue 536, p7 

    The article discusses research being done on stem cell transplantation. It references a study by V. Costa et al. published in the July-August 2007 issue of the "Value in Health." A group of researchers from Canada reported that stem cell transplantation is cost effective for the treatment of...

  • [1] Developmental outcome in five children with Hurler syndrome after stem cell transplantation: a pilot study/[2] Developmental outcomes in children with Hurler syndrome after stem cell transplantation.  // Current Medical Literature: Lysosomal Storage Disease;2008, Vol. 8 Issue 1, p27 

    The article reports on the medical study on the developmental outcomes in children with Hurler syndrome after stem cell transplantation. It states that a relative reduction in head circumference and a significant decrease in white matter lesions was found in children. It adds that the authors...

  • Stem cell research-why is it regarded as a threat? Lachmann, Peter // EMBO Reports;Mar2001, Vol. 2 Issue 3, p165 

    This article focuses on the economic and ethical arguments made against research with human embryonic stem cells. It is indisputable that most novel medical technologies are expensive. However, they usually get cheaper as the scale on which they are used increases. A few decades later, bone...

  • Artificial chromosomes correct a genetic defect. Aldhous, Peter // New Scientist;6/10/2006, Vol. 190 Issue 2555, p11 

    The article offers information on a study that describes the future of gene therapy. According to Mitsuo Oshimura of Tottori University in Japan, stem cells have great potential as a tool for gene therapy because they should divide and give rise to new tissues once transplanted in the body....

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics